AMLX - Amylyx Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AMLX is currently covered by 7 analysts with an average price target of $13.33. This is a potential upside of $4.92 (58.5%) from yesterday's end of day stock price of $8.41.

Amylyx Pharmaceuticals's activity chart (see below) currently has 34 price targets and 55 ratings on display. The stock rating distribution of AMLX is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.42% with an average time for these price targets to be met of 141.5 days.

Highest price target for AMLX is $16, Lowest price target is $8, average price target is $10.71.

Most recent stock forecast was given by CHRIS SHIBUTANI from GOLDMAN SACHS on 10-Jul-2025.

Currently out of the existing stock ratings of AMLX, 24 are a BUY (75%), 8 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$2.32 (30.21%)

$4

4 days ago
(10-Jul-2025)

4/8 (50%)

$2.61 (35.32%)

178

Buy

$12

$4.32 (56.25%)

27 days ago
(17-Jun-2025)

1/3 (33.33%)

$6.67 (125.14%)

188

Buy

$8

$0.32 (4.17%)

$7

2 months ago
(14-May-2025)

2/5 (40%)

$3.65 (83.91%)

111

Buy

$16

$8.32 (108.33%)

$12

2 months 5 days ago
(09-May-2025)

4/21 (19.05%)

$11.39 (247.07%)

177

Hold

$10

$2.32 (30.21%)

2 months 7 days ago
(07-May-2025)

1/4 (25%)

$5.13 (105.34%)

187

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AMLX (Amylyx Pharmaceuticals) average time for price targets to be met?

On average it took 141.5 days on average for the stock forecasts to be realized with a an average price target met ratio 33.42

Which analyst has the current highest performing score on AMLX (Amylyx Pharmaceuticals) with a proven track record?

ANDREW FEIN

Which analyst has the current lower performing score on AMLX (Amylyx Pharmaceuticals) with a proven track record?

GEOFF MEACHAM

Which analyst has the most public recommendations on AMLX (Amylyx Pharmaceuticals)?

Andrew Fein works at HC WAINWRIGHT and has 22 price targets and 18 ratings on AMLX

Which analyst is the currently most bullish on AMLX (Amylyx Pharmaceuticals)?

Andrew Fein with highest potential upside - $8.32

Which analyst is the currently most reserved on AMLX (Amylyx Pharmaceuticals)?

Umer Raffat with lowest potential downside - -$0

Amylyx Pharmaceuticals in the News

AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) on behalf of long-term stockholders following a class action complaint that was filed against Amylyx on July 1, 2025 with a Class Period from November...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?